U.S. Markets closed

Stocks That Fell to 3-Year Lows in the Week of March 22

- By Shuda Xia

UBS Group AG (UBS), AutoNation Inc. (AN), Mednax Inc. (MD) and Amdocs Ltd. (DOX) have declined to three-year lows.

UBS Group declined to $11.88

The price of UBS Group shares declined to $11.88 on March 22, which is only 2.3% above the three-year low of $11.61.

UBS is a Swiss investment bank and financial services company. It is known for its strict bank-client confidentiality and culture of banking secrecy.


The company has a market cap of $46.05 billion; its shares were traded around $11.88 with a price-earninigs ratio of 10.44 and a price-sales ratio of 1.54. The trailing 12-month dividend yield is 5.48%. The forward dividend yield is 5.73%.

On March 15, UBS published its 2018 annual report, which provides comprehensive and detailed information on the company, its strategies, business and governance. The company's net profit attributable to shareholders for 2018 was $4.5 billion, while its diluted earnings per share were $1.18.

AutoNation declined to $33.57

The price of AutoNation shares declined to $33.57 on March 22, which is only 2.2% above the three-year low of $32.83.

The automotive retailer is the leading provider of new and pre-owned vehicles. The company is currently the largest automotive retailer in the U.S.

AutoNation has a market cap of $3.02 billion; its shares were traded around $33.57 with a price-earnings ratio of 7.73 and a price-sales ratio of 0.14. The company had an annual average earnings growth of 9.10% over the past five years.

On Feb. 22, AutoNation announced its board of directors unanimously voted to appoint Carl Liebert as the new CEO and president, effective March 11. Liebert was also named to the company's board of directors and Mike Jackson will assume the role of executive chairman.

Mednax declined to $28.93

The price of Mednax shares declined to $28.93 on March 22, which is only 0.0% above the three-year low of $28.92.

Mednax is an American specialized health services company that focuses on neonatal, anesthesia,and pediatric physician subspecialty services. The company is the largest provider of newborn hearing screening in the U.S.

The company has a market cap of $2.54 billion; its shares were traded around $28.93 with a price-earnings ratio of 9.84 and a price-sales ratio of 0.73. Mednax had an annual average earnings growth of 9.70% over the past 10 years.

On Feb. 21, Mednax announced the closing of the previously announced private placement of $500 million aggregate principal amount of its 6.250% senior notes, due Jan. 15, 2027. The transaction resulted in $491.7 million in net proceeds, which will be used to repay a portion of its outstanding debt.

Amdocs declined to $53.83

The price of Amdocs shares declined to $53.83 on March 22, which is only 2.3% above the three-year low of $52.60.

Amdocs is an international communications technology company that focuses on providing software and services to financial services companies and digital enterprises. The company was founded in Israel, but is currently headquartered in the U.S.

The company has a market cap of $7.48 billion; its shares were traded around $53.83 with a price-earnings ratio of 22.60 and a price-sales ratio of 1.90. The trailing 12-month dividend yield is 1.86%. The forward dividend yield is 2.07%. Amdocs had an annual average earnings growth of 6.30% over the past 10 years.

On Feb. 26, the company announced that Eros Now, a digital South Asian entertainment platform, had selected Vindicia CashBox to enhance its consumer experience. Vindicia is an Amdocs company and focuses on business-to-consumer digital services monetization. The partnership aims to accelerate the subscriber growth of Eros Now globally.

Disclosure: I do not own shares of any of the companies mentioned in the article.

This article first appeared on GuruFocus.